Brecanavir (formerly GSK 640385)

GlaxoSmithKline Halts Clinical Development of Experimental PI Brecanavir  1/05/07

FDA Grants Fast Track Status for GSK/Vertex Experimental HIV Protease Inhibitor 640385 (VX-385) -7/20/05

Experimental Protease Inhibitor VX-385 from GSK and Vertex Is Active Against PI-resistant Strains of HIV - 6/15/04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 






HIV AND AIDS | HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH | TESTS |
INTERNET CONFERENCE REPORTS | LINKS | ABOUT US | CONTACT US